Replies to post #4663 on NorthWest Biotherapeutics Inc (NWBO)

[longusa]

A point I would add: a unique aspect of the Phase III DCVax-L trial is the mid-trial stop and restart for financial reasons. This could take extra time if the pre-stop and post-stop groups are analyzed separately and then as a whole. I hope they do this, as the 33 long-term pre-stop patients should be quite reflective of outcomes.